Health Canada will not be changing its recommendations for AstraZeneca’s COVID-19 vaccine despite new evidence suggesting a “stronger link” to blood clotting, the agency’s chief medical adviser, said on Wednesday.“We didn’t find any specific risk factors, such as age or sex, so we are therefore not requiring that the vaccine label be updated to restrict the use of the vaccine at this time,” Dr.